Meta-Analysis of the Efficacy and Safety of Genotype-Guided Strategy for Selection of P2Y₁₂ Inhibitors in Coronary Artery Disease

Am J Cardiol. 2020 Dec 1:136:168-170. doi: 10.1016/j.amjcard.2020.09.023. Epub 2020 Sep 19.

Authors

Salik Nazir¹, Keerat Rai Ahuja², Ahmed Elzanaty³, Neha J Patel³, Muhammad Mahmood³, Khalid Changal¹, Michael Macciocca², Rajesh Gupta⁴

Affiliations

¹ Division of Cardiology, University of Toledo Medical Center, Toledo, Ohio.
² Division of Cardiology, Reading Hospital-Tower Health System, West Reading, Pennsylvania.
³ Department of Medicine, University of Toledo Medical Center, Toledo, Ohio.
⁴ Division of Cardiology, University of Toledo Medical Center, Toledo, Ohio. Electronic address: rajesh.gupta@utoledo.edu.

PMID: 32961111
DOI: 10.1016/j.amjcard.2020.09.023

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Coronary Artery Disease / drug therapy*
Genotype
Humans
Purinergic P2Y Receptor Antagonists / adverse effects
Purinergic P2Y Receptor Antagonists / therapeutic use*
Treatment Outcome

Substances

Purinergic P2Y Receptor Antagonists